Holz FG, Schmitz-Valckenberg S, Wolf A, Agostini H, et al. A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration-the FALCON study. Graefes Arch Clin Exp Ophthalmol 2022 Feb 21. pii: 10.1007/s00417-022-05591.
PMID: 35188581